Renal failure in cirrhosis.
N Engl J Med. 2009; 361: 1279-1290
Renal failure and cirrhosis: a systematic review of mortality and prognosis.
J Hepatol. 2012; 56: 810-818
Pre-liver transplant renal dysfunction and association with post-transplant end-stage renal disease: a single-center examination of updated UNOS recommendations.
Clin Transplant. 2018; 32: e13428
Chronic renal failure after transplantation of a nonrenal organ.
N Engl J Med. 2003; 349: 931-940
Association between renal dysfunction and major adverse cardiac events after liver transplantation: evidence from an international randomized trial of everolimus-based immunosuppression.
Ann Transplant. 2018; 23: 751-757
Sirolimus conversion in liver transplant recipients with renal dysfunction: a prospective, randomized, single-center trial.
Transplantation. 2007; 83: 1389-1392
Independent risk factors and natural history of renal dysfunction in liver transplant recipients.
Liver Transpl. 2003; 9: 741-747
Risk factors of acute renal failure after liver transplantation.
Kidney Int. 2006; 69: 1073-1080
Working party proposal for a revised classification system of renal dysfunction in patients with cirrhosis.
Gut. 2011; 60: 702-709
Renal dysfunction in liver transplant candidates: evaluation, classification and management in contemporary practice.
J Nephrol Ther. 2012; ()https://doi.org/10.4172/2161-0959.S4-006
Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis.
Am J Gastroenterol. 2001; 96: 2206-2210
Prognostic importance of the cause of renal failure in patients with cirrhosis.
Gastroenterology. 2011; 140: 488-496.e4
The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.
Hepatol. 2003; 38: 258-266
Renal duplex Doppler ultrasonography: a noninvasive predictor of kidney dysfunction and hepatorenal failure in liver disease.
Hepatology. 1994; 20: 362-369
Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis.
J Hepatol. 2004; 41: 384-390
Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.
Postgrad Med J. 2008; 84: 662-670
Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome.
N Engl J Med. 2021; 384: 818-828
Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome.
J Clin Gastroenterol. 2009; 43: 680-685
Non-alcoholic fatty liver and chronic kidney disease: retrospect, introspect, and prospect.
World J Gastroenterol. 2021; 27: 1864-1882
Renal dysfunction in hepatic disease: early identification with renal duplex Doppler US in patients who undergo liver transplantation.
Radiology. 1992; 183: 801-806
Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver.
Gut. 2002; 50: 106-110
Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis.
Hepatol. 2014; 59: 1532-1542
Renal dysfunction in end-stage liver disease and post-liver transplant.
Clin Liver Dis. 2014; 18: 543-560
Estimating glomerular filtration rate in cirrhosis using creatinine-based and cystatin C-based equations: systematic review and meta-analysis.
Liver Transpl. 2021; 27: 1538-1552
Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis.
J Hepatol. 2012; 57: 267-273
Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis.
Dig Dis Sci. 2012; 57: 2362-2370
Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury.
Hepatol Aug. 2014; 60: 622-632
Clinical utility of urinary neutrophil gelatinase-associated lipocalin and serum cystatin C in a cohort of liver cirrhosis patients with renal dysfunction: a challenge in the diagnosis of hepatorenal syndrome.
Eur J Gastroenterol Hepatol. 2019; 31: 692-702
Simultaneous liver kidney transplantation.
Transplant Int. 2019; 32: 343-352
Nonalcoholic steatohepatitis is the most rapidly growing indication for simultaneous liver kidney transplantation in the United States.
Transplant. 2016; 100: 607-612
Association of pretransplant renal function with liver graft and patient survival after liver transplantation in patients with nonalcoholic steatohepatitis.
Liver Transplant. 2019; 25: 399-410
Obesity does not significantly impact outcomes following simultaneous liver kidney transplantation: review of the UNOS database – a retrospective study.
Transplant Int. 2019; 32: 206-217
Intraoperative hemodialysis during liver transplantation: a decade of experience.
Liver Transplant. 2014; 20: 756-764
Outcome analysis of continuous intraoperative renal replacement therapy in the highest acuity liver transplant recipients: a single-center experience.
Surgery. 2017; 161: 1279-1286
Benefits of intraoperative continuous renal replacement therapy during liver transplantation in patients with renal dysfunction.
Transplant Proc. 2017; 49: 1344-1350
Does the standard vs piggyback surgical technique affect the development of early acute renal failure after orthotopic liver transplantation?.
Transplant Proc. 2003; 35: 1913-1914
Liver transplantation without venovenous bypass: does surgical approach matter?.
Transplant Direct. 2018; 4: e348
Venovenous bypass is associated with a lower incidence of acute kidney injury after liver transplantation in patients with compromised pretransplant renal function.
Anesth Analg. 2017; 125: 1463-1470
Chronic renal dysfunction late after liver transplantation.
Liver Transpl. 2002; 8: 916-921
Chronic renal failure following liver transplantation: a retrospective analysis.
Transplantation. 1998; 66: 59-66
End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment.
Transplantation. 2001; 72: 1934-1939
End-stage renal disease in liver transplants.
Clin Transplant. 2001; 15: 66-69
Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I.
Liver Transplant. 2002; 8: 91-109
Mechanisms of nephrotoxicity.
Transplantation. 2000; 69: Ss5-Ss10
Immunosuppressant-induced nephropathy: pathophysiology, incidence and management.
Drug Saf. 1999; 21: 471-488
Loss of glomerular function and tubulointerstitial fibrosis: cause or effect?.
Kidney Int. 1994; 45: 345-351
Everolimus with early withdrawal or reduced-dose calcineurin inhibitors improves renal function in liver transplant recipients: a systematic review and meta-analysis.
Clin Transplant. 2017; 31https://doi.org/10.1111/ctr.12872
Delayed calcineurin inhibitor introduction and renal outcomes in liver transplant recipients receiving basiliximab induction.
Clin Transplant. 2018; 32: e13415
Basiliximab with delayed tacrolimus improves short-term renal outcomes post-liver transplantation-a real-world experience.
Transplant Proc. 2021; 53: 1541-1547
Induction immunosuppression in adults undergoing liver transplantation: a network meta-analysis.
Cochrane Database Syst Rev. 2020; 1: Cd013203
Use of fenoldopam to control renal dysfunction early after liver transplantation.
Liver Transplant. 2004; 10: 986-992
Fenoldopam to prevent acute kidney injury after major surgery-a systematic review and meta-analysis.
Crit Care. 2015; 19: 449
Fenoldopam mesylate and renal function in patients undergoing liver transplantation: a randomized, controlled pilot trial.
Anesth Analg. 2004; 99: 1604-1609
Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial.
Crit Care Med. 2004; 32: 1310-1315
Serum cystatin C in the United States: the third national health and nutrition examination survey (NHANES III).
Am J Kidney Dis. 2008; 51: 385-394
Dopazo, C., Charco, R., Caralt, M., Pando, E., Lázaro, J. L., Gómez-Gavara, C., Castells, L., & Bilbao, I. (2018). Low Total Dose of Anti-Human T-Lymphocyte Globulin (ATG) Guarantees a Good Glomerular Filtration Rate after Liver Transplant in Recipients with Pretransplant Renal Dysfunction. Can J Gastroenterol Hepatol 2018.
#Peritransplant #Renal #Dysfunction #Liver #Transplant #Candidates